Teotia believes in matching the procedure to the patient, not the other way around
During that conference, she discussed issues related to deposition protocol and the short-form complaints
In one study, GLP-1s were found to act directly on skin cells, potentially worsening facial thinning beyond fat loss alone
[88] In March 2026, the CHMP recommended granting a conditional marketing authorization for Kayshild (semaglutide), a GLP-1 receptor agonist for the treatment of non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis, a serious disease where fat deposits accumulate in the liver causing inflammation
affected people may use fewer (or no) substances and not agonize over it
ACT 2: Tirzepatide (Mounjaro & Zepbound) More Flexibility, Same Discipline Tirzepatide is a dual GIP/GLP-1 receptor agonist, making it pharmacologically distinct from semaglutide